reports
Regeneron Pharmaceuticals Inc: 2 directors
Two Directors at Regeneron Pharmaceuticals Inc sold after exercising options/sold 122,830 shares at between 974.303USD and 979.225USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary ...
More than $9 Million Awarded to High School Scientists and Engineers a...
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024 Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world’s largest pre-college science, technology, engineering and math (STEM) competition. TARRYTOWN, N.Y. and WASHINGTON, D.C., May 17, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Grace Sun, 16, of Lexington, Kentucky, won the $75,000 top award, the George D. Yancopoulos Inno...
EOG Resources Inc: 2 directors
Two Directors at EOG Resources Inc sold/sold after exercising options 18,776 shares at between 130.037USD and 130.305USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all...
Moody’s Ratings rates CNO’s senior unsecured notes Baa3
New York , May 9, 2024 – Moody's Ratings (Moody's) has assigned a Baa3 rating to $700 million of 10-year senior unsecured notes being issued by CNO Financial Group, Inc. (CNO; NYSE: CNO). CNO intends to use the net proceeds from the offering for general corporate purposes, which may include the rede...
CNO Financial Group Inc: 2 directors
Two Directors at CNO Financial Group Inc sold 21,718 shares at between 28.250USD and 28.261USD. The significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
Moody's Ratings assigns Aaa ratings to Johnson & Johnson's sr. notes; ...
Moody's Ratings (Moody's) assigned Aaa ratings to the new USD and EUR denominated senior unsecured note offerings of Johnson & Johnson ("J&J"). There are no changes to J&J's existing ratings including the Aaa senior unsecured long-term rating or the Prime-1 short-term rating. The outlook remains unc...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatm...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) If approved, Dupixent would be the first treatment in the U.S. indicated for adolescents aged 12-17 years with inadequately controlled CRSwNP, a condition driven in part by underlying type 2 inflammation that obstructs the sinuses and nasal passages and can lead to a loss of sense of smell Current treatment options for adolescents with CRSwNP leave many patients with uncontrolled disease and often result in the recurrence of nasal polyps TARRY...
Moody’s Ratings rates CNO’s senior unsecured notes Baa3
New York , May 9, 2024 – Moody's Ratings (Moody's) has assigned a Baa3 rating to $700 million of 10-year senior unsecured notes being issued by CNO Financial Group, Inc. (CNO; NYSE: CNO). CNO intends to use the net proceeds from the offering for general corporate purposes, which may include the rede...
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Lev...
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks Preliminary data detailed in an ASGCT oral presentation include results for one of the youngest children in the world to receive a gene therapy for genetic deafness Ongoing Phase 1/2 CHORD trial is currently enrolling infants and children in the U.S., UK and Spain TARRYTOWN, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the investigatio...
Devon Energy Corp: 1 director
A director at Devon Energy Corp sold 20,000 shares at 51.040USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Résultats du premier trimestre de 2024 de Suncor Énergie
Sauf indication contraire, toute l'information financière est non auditée et présentée en dollars canadiens, et elle est tirée des états financiers consolidés résumés de la Société, qui sont fondés sur les principes comptables généralement reconnus (les « PCGR ») du Canada, plus précisément les Normes internationales d'information financière (les « IFRS ») publiées par l'International Accounting Standards Board (l'« IASB »), et qui ont été préparés conformément à la Norme comptable internationale (« IAS ») 34, Information financière intermédiaire. Les volumes de production sont présentés selon...
Suncor Énergie déclare un dividende
Tous les montants sont en dollars canadiens.Calgary, Alberta--(Newsfile Corp. - 7 mai 2024) - Le conseil d'administration de Suncor Énergie (TSX: SU) (NYSE: SU) a approuvé un dividende trimestriel de 0,545 $ par action sur ses actions ordinaires, payable le 25 juin 2024 aux actionnaires inscrits à la fermeture des bureaux le 4 juin 2024. Suncor Énergie est la plus importante société énergétique intégrée du Canada. Les activités de Suncor sont reliées notamment au développement, à la production et la valorisation des sables bitumineux; à la production pétrolière extracôtière; au raffinage du p...
Suncor Énergie présente les résultats du vote tenu à l'assemblée génér...
Calgary, Alberta--(Newsfile Corp. - 7 mai 2024) - Suncor (TSX: SU) (NYSE: SU) a tenu aujourd'hui son assemblée générale annuelle des actionnaires à Calgary. Au total, 877 654 867 actions (représentant approximativement 68,19 % des actions ordinaires en circulation) étaient représentées en personne ou par procuration.Les actionnaires ont voté comme suit sur les propositions avant l'assemblée :Les actionnaires ont élu les onze membres suivants au Conseil d'administration (dont dix sont indépendants), avec les votes afférents aux actions représentées étant en faveur des administrateurs individuel...
Occidental Announces First Quarter 2024 Results
Occidental Announces First Quarter 2024 Results HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: OXY) today announced its first quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the section of the company’s website, . The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Wednesday, May 8, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international call...
Regeneron Announces Investor Conference Presentations
Regeneron Announces Investor Conference Presentations TARRYTOWN, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on Tuesday, May 14, 2024Jefferies Global Healthcare Conference at 8:30 a.m. ET on Wednesday, June 5, 2024Goldman Sachs 45th Annual Global Healthcare Conference at 8:00 a.m. ET on Tuesday, June 11, 2024 The sessions may be accessed from the "Investors & Media" page of Regeneron's website at . Replays and transcripts of the web...
Pfizer Announces New Chief Strategy and Innovation Officer
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla. He joins Pfizer from Citi, where he served as Head of Global Healthcare, Managing Director Equity Research. Prior to joining Citi in 2011, Dr. Baum covered European Pharmaceuticals at Morgan Stanley for 14 years and earlier in his career was a practicing physician at the Royal Nation...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Suncor Energy Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 29 April 2024 in which Moody's reassessed the appropriateness of the ratings in the cont...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.